Stanford researchers have developed an innovative optical architecture that enables projection-based vat photopolymerization (VP) 3D printers to significantly expand the printable area without sacrificing resolution, speed, or structural integrity.
Stanford scientists have developed a lateral flow diagnostic platform that detects pathogen DNA without nucleic acid amplification, delivering results visible to the naked eye in under 30 minutes.
Stanford scientists have discovered that theta oscillations in the anterior cingulate cortex can detect empathic states, and that targeting the upstream orexin circuit can modulate empathy-related behaviors.
Stanford researchers have developed a macrophage-targeted PEGylated liposome ("PEGosome") platform that selectively delivers polyethylene glycol (PEG) to inflammatory monocytes and macrophages driving neuroinflammation in diseases such as multiple sclerosis (MS), Alzheimer's d
Stanford researchers have developed a first-to-market personalized surgical system that optimizes quadriceps tendon (QT) harvesting for ACL reconstruction.
Old age is attributed to over fifty percent of the global disease burden. While aging is a sign of normal development early in life, it leads to the loss of youthful traits and bodily function in later years.
Stanford researchers have patented methods to improve phagocytosis, the process by which macrophages clear protein aggregates, dying cells, and debris, to treat age-related diseases.
Researchers at Stanford have developed a clinically applicable method of bone marrow conditioning for stem cell transplantation or treatment of hematologic malignancies.
Stanford researchers have developed a novel approach to selectively regulate and monitor immune responses in specific mucosal tissues, using the GPCR receptor GPR25 and its ligand CXCL17, which targets lymphocyte localization to non-intestinal mucosal tissues, enabling selecti
Stanford scientists have developed a high throughput screening method to identify therapeutics known as translational activators to treat protein synthesis disorders and ribosomopathies.
Stanford researchers have developed tissue-based profiling by deep sequencing for detection of Minimal Residual Disease (MRD) by tracking patient-specific tumor mutations in post-chemotherapy tissue samples, enabling a highly sensitive, molecular-level assessment of residual c
Stanford researchers have developed a new on-chip system for laser microdissection that enables more reliable isolation of single cells or small regions of tissue and permits long-term sample storage.
Researchers at Stanford have created a method to differentiate human pluripotent stem cells (hPSCs) into >90% pure hematopoietic stem cell (HSC)-like cells, which serve as progenitors to blood and immune cells.